| 000 | 01519 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515115804.0 | ||
| 264 | 0 | _c20080718 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a0021-9509 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarrier, M | |
| 245 | 0 | 0 |
_aProtective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial. _h[electronic resource] |
| 260 |
_bThe Journal of cardiovascular surgery _cApr 2008 |
||
| 300 |
_a249-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAorta _xphysiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xmortality |
| 650 | 0 | 4 | _aConstriction |
| 650 | 0 | 4 | _aCoronary Artery Bypass |
| 650 | 0 | 4 |
_aCreatine Kinase, MB Form _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xetiology |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xetiology |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aPyridoxal Phosphate _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aEmery, R | |
| 700 | 1 | _aKandzari, D E | |
| 700 | 1 | _aHarrington, R | |
| 700 | 1 | _aGuertin, M C | |
| 700 | 1 | _aTardif, J C | |
| 773 | 0 |
_tThe Journal of cardiovascular surgery _gvol. 49 _gno. 2 _gp. 249-53 |
|
| 999 |
_c17928513 _d17928513 |
||